Anne Carol Goldberg, MD, FACP, FAHA, FNLA is an endocrinologist and lipid specialist. She received her medical degree from University of Maryland and completed internal medicine residency at Michael Reese Hospital, Chicago, Illinois, and endocrinology fellowship at Washington University School of Medicine, St. Louis, Missouri, where she is now Professor of Medicine. Research interests include therapies for hyperlipidemia and the treatment of familial hypercholesterolemia. She has conducted clinical trials involving most classes of lipid-modifying drugs. She treats adults and children with dyslipidemia, including familial hypercholesterolemia, and has a lipoprotein apheresis program. Awards include the National Forum for Heart Disease and Stroke Prevention Public Policy Award, the Foundation of the National Lipid Association Clinician/Educator Award, and Washington University School of Medicine Distinguished Clinician Award.
She is a past President of the National Lipid Association (NLA) and immediate past president of the Foundation of the NLA. She chaired the NLA Expert Panel on Familial Hypercholesterolemia and was a member of the ACC/AHA Blood Cholesterol Expert Panel for the 2013 ACC/AHA Cholesterol Guidelines and of the task force for the Endocrine Society Clinical Practice Guideline on Evaluation and Treatment of Hypertriglyceridemia. She is currently the Chief Science Officer of the NLA.